Mitchell Levine's Insider Trades & SAST Disclosures

Mitchell Levine's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 87,500 Option to Purchase Common Stock done . Disclosure was reported to the exchange on March 15, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2022 87,500 87,500 - - Option to Purchase Common Stock
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2022 87,500 87,500 - - Option to Purchase Common Stock
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.17 per share. 15 Mar 2022 25,000 87,080 (0%) 0% 1.2 29,150 Common Stock, no par value
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2021 20,000 0 - - Restricted Stock Units
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2021 20,000 66,700 (0%) 0% 0 Common Shares, no par value
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 Apr 2021 4,620 62,080 (0%) 0% 0 Common Shares, no par value
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2021 255,000 255,000 - - Employee Stock Option (right to buy)
Insight Molecular Diagnost...
Mitchell Levine CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 10,121 46,700 (0%) 0% - Common Stock
Insight Molecular Diagnost...
Mitchell Levine Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.32 per share. 03 Aug 2020 10,000 36,579 (0%) 0% 1.3 13,200 Common Stock, no par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades